Verrica Pharmaceuticals Company Overview 2024

Loading viewer...

investor_presentation

Format: PDF investor_presentation

Verrica Pharmaceuticals is a dermatology therapeutics company developing clinician-administered therapies for skin diseases with high unmet medical needs. The company focuses on products with reimbursement potential, including YCANTH (VP-102) for molluscum contagiosum and external genital warts, and VP-315 for basal cell carcinoma.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Verrica Pharmaceuticals

View all →

Verrica Pharmaceuticals 2024 Company Overview - YCANTH Molluscum Contagiosum

investor_presentation

51 Pages

Similar investor_presentations from other companies

Browse all →

Company Web Slides February 2017

investor_presentation

6 Pages

Unknown

Natural Grocers Investor Presentation August 2021

investor_presentation